UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

Tissue inhibitor of metalloproteinases-1 in breast cancer

Endocrine-related cancer, 2005-06, Vol.12 (2), p.215-227

2005

Volltextzugriff (PDF)

Evaluation of sample handling in relation to levels of tissue inhibitor of metalloproteinases-1 measured in blood by immunoassay

The International journal of biological markers, 2003-07, Vol.18 (3), p.170-176

2003

Volltextzugriff (PDF)

Investigation of tissue inhibitor of metalloproteinases 1 in plasma from colorectal cancer patients and blood donors by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry

The International journal of biological markers, 2007-04, Vol.22 (2), p.89-94

2007

Volltextzugriff (PDF)

Levels of tissue inhibitor of metalloproteinases 1 in plasma and urine from patients with bladder cancer

The International journal of biological markers, 2006, Vol.21 (1), p.6-11

2006

Volltextzugriff (PDF)

Evaluation of sample handling in relation to levels of tissue inhibitor of metalloproteinases-1 measured in blood by immunoassay

The International journal of biological markers, 2003, Vol.18 (3), p.170-176

2003

Volltextzugriff (PDF)

Abstract P4-07-04: Preoperative Plasma Concentration of MMP-9/TIMP-1 Complexes Is Not Associated with Disease Outcome in Primary Breast Cancer (N=483)

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P4-P4-07-04

2010

Volltextzugriff (PDF)

Abstract P4-08-08: Cross Reactivity of Clinically Validated Anti-HER2 Antibodies

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P4-P4-08-08

2010

Volltextzugriff (PDF)

Tumor Tissue Levels of Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Marker in Primary Breast Cancer

Clinical cancer research, 2004-04, Vol.10 (7), p.2289-2298

2004

Volltextzugriff (PDF)

Tumor markers: from laboratory to clinical utility

Molecular & cellular proteomics, 2003-06, Vol.2 (6), p.378-387

2003

Volltextzugriff (PDF)

Tumor Tissue Concentrations of the Proteinase Inhibitors Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and Plasminogen Activator Inhibitor Type 1 (PAI-1) Are Complementary in Determining Prognosis in Primary Breast Cancer

Molecular & cellular proteomics, 2003-03, Vol.2 (3), p.164-172

2003

Volltextzugriff (PDF)

P4-01-17: TIMP-1 Over-Expression Confers Resistance of MCF-7 Breast Cancer Cells to Fulvestrant

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P4-P4-01-17

2011

Volltextzugriff (PDF)

Measurement of the Uncomplexed Fraction of Tissue Inhibitor of Metalloproteinases-1 in the Prognostic Evaluation of Primary Breast Cancer Patients

Molecular & cellular proteomics, 2005-04, Vol.4 (4), p.483-491

2005

Volltextzugriff (PDF)

Validation of the predictive value of tissue inhibitor of metalloproteinases-1 for the response to first-line chemotherapy in metastatic breast cancer

31st Annual San Antonio Breast Cancer Symposium,2008-12-10 - 2008-12-14, 2009, Vol.69 (2), p.363

2009

Volltextzugriff (PDF)

Levels of tissue inhibitor of metalloproteinases 1 in plasma and urine from patients with bladder cancer

The International journal of biological markers, 2006, Vol.21 (1), p.6-11

2006

Volltextzugriff (PDF)

TIMP-1 as a new cancer biomarker: From bench to bed and back again

INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2007, Vol.22 (1), p.55

2007

Volltextzugriff (PDF)

Human epidermal growth factor receptor 2 (HER2) immunoreactivity: specificity of three pharmacodiagnostic antibodies

Histopathology, 2011-11, Vol.59 (5), p.975-983

2011

Volltextzugriff (PDF)

Banking of Biological Fluids for Studies of Disease-associated Protein Biomarkers

Molecular & cellular proteomics, 2008-10, Vol.7 (10), p.2061-2066

2008

Volltextzugriff (PDF)

TIMP-1 as a tumor marker in breast cancer - An update

Acta oncologica, 2008, Vol.47 (4), p.580-590

2008

Volltextzugriff (PDF)

Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines

BMC cancer, 2016-01, Vol.16 (26), p.34-34, Article 34

2016

Volltextzugriff (PDF)

Acquisition of docetaxel resistance in breast cancer cells reveals upregulation of ABCB1 expression as a key mediator of resistance accompanied by discrete upregulation of other specific genes and pathways

Tumor biology, 2015-06, Vol.36 (6), p.4327-4338

2015

Volltextzugriff (PDF)

Primary Tumor Levels of Tissue Inhibitor of Metalloproteinases-1 Are Predictive of Resistance to Chemotherapy in Patients with Metastatic Breast Cancer

Clinical cancer research, 2006-12, Vol.12 (23), p.7054-7058

2006

Volltextzugriff (PDF)

TIMP‑1 Increases Expression and Phosphorylation of Proteins Associated with Drug Resistance in Breast Cancer Cells

Journal of proteome research, 2013-09, Vol.12 (9), p.4136-4151

2013

Volltextzugriff (PDF)

Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study

BMC cancer, 2013-12, Vol.13 (1), p.598-598, Article 598

2013

Volltextzugriff (PDF)

TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression

Tumor biology, 2013-12, Vol.34 (6), p.3839-3851

2013

Volltextzugriff (PDF)

Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study

BMC cancer, 2009-09, Vol.9 (1), p.322-322, Article 322

2009

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(40)
Tagungsberichte
(2)

Sprache

Englisch
(42)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Humans
(24)
Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Female
(19)
Oncology
(15)
Breast Cancer
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Breast Neoplasms - Pathology
(9)
Enzyme-Linked Immunosorbent Assay
(9)
Middle Aged
(9)
Prognosis
(9)
Tissue Inhibitor Of Metalloproteinase-1 - Metabolism
(9)
Breast Neoplasms - Metabolism
(8)
Adult
(7)
Aged
(7)
Tissue Inhibitor Of Metalloproteinase-1 - Blood
(7)
Tumors
(7)
Breast Neoplasms - Diagnosis
(6)
Timp-1
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tissue inhibitor of metalloproteinases-1 in breast cancer

Evaluation of sample handling in relation to levels of tissue inhibitor of metalloproteinases-1 measured in blood by immunoassay

Investigation of tissue inhibitor of metalloproteinases 1 in plasma from colorectal cancer patients and blood donors by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry

Levels of tissue inhibitor of metalloproteinases 1 in plasma and urine from patients with bladder cancer

Evaluation of sample handling in relation to levels of tissue inhibitor of metalloproteinases-1 measured in blood by immunoassay

Abstract P4-07-04: Preoperative Plasma Concentration of MMP-9/TIMP-1 Complexes Is Not Associated with Disease Outcome in Primary Breast Cancer (N=483)

Abstract P4-08-08: Cross Reactivity of Clinically Validated Anti-HER2 Antibodies

Tumor Tissue Levels of Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Marker in Primary Breast Cancer

Tumor markers: from laboratory to clinical utility

Tumor Tissue Concentrations of the Proteinase Inhibitors Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and Plasminogen Activator Inhibitor Type 1 (PAI-1) Are Complementary in Determining Prognosis in Primary Breast Cancer

P4-01-17: TIMP-1 Over-Expression Confers Resistance of MCF-7 Breast Cancer Cells to Fulvestrant

Measurement of the Uncomplexed Fraction of Tissue Inhibitor of Metalloproteinases-1 in the Prognostic Evaluation of Primary Breast Cancer Patients

Validation of the predictive value of tissue inhibitor of metalloproteinases-1 for the response to first-line chemotherapy in metastatic breast cancer

Levels of tissue inhibitor of metalloproteinases 1 in plasma and urine from patients with bladder cancer

TIMP-1 as a new cancer biomarker: From bench to bed and back again

Human epidermal growth factor receptor 2 (HER2) immunoreactivity: specificity of three pharmacodiagnostic antibodies

Banking of Biological Fluids for Studies of Disease-associated Protein Biomarkers

TIMP-1 as a tumor marker in breast cancer - An update

Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines

Acquisition of docetaxel resistance in breast cancer cells reveals upregulation of ABCB1 expression as a key mediator of resistance accompanied by discrete upregulation of other specific genes and pathways

Primary Tumor Levels of Tissue Inhibitor of Metalloproteinases-1 Are Predictive of Resistance to Chemotherapy in Patients with Metastatic Breast Cancer

TIMP‑1 Increases Expression and Phosphorylation of Proteins Associated with Drug Resistance in Breast Cancer Cells

Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study

TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression

Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study

Suchergebnisse filtern